Ikonisys S.A. (ALIKO.PA)

1.4900 0.0000 (0.00%) As of 09:00AM CEST. Market open.

Ikonisys S.A.

62 Rue De Caumartin
Paris 75009
France
33 39 348 901 9064
https://www.ikonisys.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 11

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Mario P. Crovetto	MD. CEO & Director	25k	N/A	1954
Dr. Michael W. Kilpatrick Ph.D.	Founder & CSO	N/A	N/A	N/A
Mr. Alessandro Mauri	Administrative & Financial Director	N/A	N/A	N/A
Mr. Bill Kochiss	Technical Director	N/A	N/A	N/A
Mr. Jurgen Schipper	Chief Commercial Officer	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Ikonisys S.A., a cell based diagnostics company, engages in the design, manufacturing, marketing, and sale of medical diagnostic products for various cancers in the United States and Europe. It offers Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, and real-time image capture and analysis; oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; and oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of rearrangements of the gene encoding anaplastic lymphoma kinase (ALK). The company also provides oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene, which is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer CS, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; Ikonisoft explorer tissue, a FISH scanning application for analysis of various tissue section hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. Ikonisys S.A. was incorporated in 2021 and is based in Paris, France.

Corporate governance

Ikonisys S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.